Health Highlights: Oct. 4, 2021

New, better antivirals against COVID-19 are on the way. On Friday, drug giant Merck announced it would seek FDA emergency use approval for a powerful new antiviral, molnupiravir. At least two more such drugs that target the SARS-CoV-2 virus are in the pipeline from other companies, and could save thousands of lives. Read more
Early in pandemic, Facebook was a lifeline. A new survey of Facebook users found that in the first weeks of the COVID-19 pandemic in 2020, users met on the social media platform to share largely accurate, supportive information. Unfortunately that didn't last, and misinformation began to creep in. Read more
U.S. passes 700,000 lives lost to COVID-19. A high percentage of unvaccinated people and a surging Delta variant have now pushed the U.S. death toll from COVID-19 past 700,000, statistics show. Many of the deaths are occurring in the South, and deaths among people under the age of 55 are becoming more common. Read more
J & J seeks approval for COVID vaccine booster shot. U.S. Food and Drug Administration authorization of a booster shot of Johnson & Johnson's single-dose COVID-19 vaccine will be sought by the company early this week, officials say. Over 15 million Americans have received a dose of the vaccine. Read more
Related Posts
Hormone Replacement Therapy Might Raise Women’s Risk for Dementia
THURSDAY, June 29, 2023 (HealthDay News) -- Women taking hormone replacement...
La tendencia anti-vacunas podría perjudicar a los perros mascota, con la mitad de los dueños en contra de la inmunización
JUEVES, 7 de septiembre de 2023 (Noticias de HealthDay) — Algunas personas...
Eligibility Criteria May Influence Disparity in Multiple Myeloma Trial Enrollment
MONDAY, May 8, 2023 (HealthDay News) -- Eligibility criteria may contribute to...
Pandemic’s Early Days Hit Nurses Hard: Report
THURSDAY, April 28, 2022 (HealthDay News) -- Frontline nurses were plagued by...